Document is current
Any future updates will be listed below
-
Authors
Akolgo, Gideon A.
Partridge, Benjamin M.
D. Craggs, Timothy
Amewu, Richard K.
-
Funding
Funding for this research was provided by:
Global Challenges Research Fund ((164187, University of Sheffield, RBV1, UG), (164187, University of Sheffield, RBV1, UG), (164187, University of Sheffield, RBV1, UG), (164187, University of Sheffield, RBV1, UG))
- License Information
-
More Information
Article History
Received: 28 December 2022
Accepted: 25 June 2023
First Online: 27 July 2023
Declarations
:
: This study was carried out at the Department of Chemistry, University of Ghana. Clinical samples were taken at Agogo Presbyterian Hospital, Ghana as part of the routine diagnostic procedure and case confirmation recommended by the World Health Organization (WHO) and sent to the DC for f-TLC analysis. The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of Noguchi Memorial Institute of Medical Research (NMIMR) (Study number: NMIMR-IRB CPN 024/18–19). In addition, written consent was obtained from all adult participants and legal guardians, or parents of any child participant provided informed written consent on the child’s behalf. To ensure anonymity, personal information such as names, and other personal identifiers associated with patient’s samples were replaced with codes.
: Not applicable.
: The authors declare no competing interests.
